Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 7 Sarcoma 5 Melanoma 5 Lymphoma, Non-Hodgkin 5 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasms 4 Endometrial Neoplasms 4 Carcinoma, Hepatocellular 4 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Myeloid, Acute 3 Kidney Neoplasms 3 Glioblastoma 3 Squamous Cell Carcinoma of Head and Neck 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Lymphoma, Mantle-Cell 2 Liver Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hodgkin Disease 2 Fallopian Tube Neoplasms 2 Congenital Abnormalities 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1

Interventions

Bevacizumab 234 Fluorouracil 220 Oxaliplatin 216 Irinotecan 215 Leucovorin 199 Capecitabine 153 Cetuximab 146 Panitumumab 70 Folfox protocol 51 regorafenib 43 Radiotherapy 38 pembrolizumab 37 IFL protocol 36 HMPL-013 36 trifluridine tipiracil drug combination 32 Nivolumab 32 Drug Therapy 26 Neoadjuvant Therapy 24 Trifluridine 18 Celecoxib 18 tislelizumab 17 XELOX 17 sintilimab 16 Trastuzumab 16 durvalumab 15 atezolizumab 15 aflibercept 15 Chemotherapy, Adjuvant 15 Biopsy 15 apatinib 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colorectal Neoplasms × temsirolimus × Clear all

NCT00827684 2011-06-08

TIRASMUS

Vejle Hospital

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡